WHO/Yoshi Shimizu
© Credits

Improving access to prevention, testing and treatment of HIV and STIs

Countries and areas in the WHO Western Pacific Region have made considerable progress in preventing and controlling the HIV epidemic. Governments have scaled up access to life-saving antiretroviral therapy.  An estimated 81% of people living with HIV (PLHIV) who know their status in the Region had access to antiretroviral therapy at the end of 2022.

Despite this progress, many obstacles lie on the path to ending the HIV epidemic. WHO Western Pacific Regional Office supports Member States to improve access to prevention, testing and treatment of HIV and sexually transmitted infections (STIs) by:  

  • Advocating towards safe sex (including promoting condom usage) and against stigma and discrimination.  
  • Providing technical support for prevention (including pre-exposure prophylaxis, or PrEP), and strengthening epidemiological and programmatic information systems.
  • Providing technical support for Member States to promote adaptation of WHO guidelines for HIV and STIs.
  • Providing technical support for Member States to expand access to quality HIV and STI testing, treatment and care services.
  • Supporting countries to strengthen surveillance systems for HIV and STIs
  • Working towards integration of HIV, STI and viral hepatitis within primary health care settings 

Regional publications

All →
Addressing trust through digitally enabled community engagement approaches in HIV/AIDS

The coronavirus disease (‎COVID-19)‎ pandemic caused severe disruptions in HIV/AIDS programming and service delivery, negatively impacting Cambodia’s...

Funding of key services for HIV, viral hepatitis and sexually transmitted infections for selected countries in the Western Pacific Region

Under Universal Health Coverage, all people should have access to quality health services that meet their needs without incurring financial hardship. Rapid...

Second National Consultation on the Use of Antiretroviral Pre-exposure Prophylaxis (‎PrEP)‎ to Prevent HIV Acquisition, 4 June 2018, Kuala Lumpur, Malaysia : meeting report

Oral pre-exposure prophylaxis of HIV infection (PrEP) is defined as the use of antiretroviral drugs by people who do not have HIV infection to prevent...

Multimedia

All →